Strides Pharma – 480
As we posted our views in our last post about the stock price moves
effected due to currency depreciation as well as technical reasons of being
defensive relating to IT and pharma. IT story was more about valuations and
while the pharma was lagging behind. It has also started performing after
continuous declines of many quarters. It has not started showing expected
profits but the technical + news factor set up are clearly...
